Ghost Shot: Pfizer Quietly Confesses It Will Never Manufacture Authentic FDA Approved COVID Vaccines

Company claims it is production Comirnaty product with new formula.

The August 23, 2021 FDA approval associated with Pfizer’s Comirnaty vaccine was a cause for celebration. Notable as a turning point in the battle against COVID19, the announcement was highly publicized with the Biden Administration with the apparent intention to extinguish “ vaccine hesitancy” and improve uptake.

It was celebrated as a cause for nationwide relief, and many Americans attained their local pharmacies under the impression, via government plus pharmaceutical propaganda, that they had been receiving an FDA-approved COVID vaccine.   Yet that will legally distinct product, as you may know it, never existed. And now we all know, via Pfizer, that it will never exist.

For the uninitiated:

Comirnaty is a legally distinct item from the emergency use authorization (EUA) shots, and It has by no means made its way to marketplace. For months on end, no this kind of vaccine has ever provided. Those who received the “ Pfizer shot(s)” have been shot with the emergency use authorization (EUA) version of the photos. See my piece within the Dossier for more info:

The information operation succeeded. There was clearly indeed an FDA accepted vaccine, at least on paper, but you couldn’t get it.

When originally confronted with this particular ordeal, Pfizer labeled this problem an inventory question that got nothing to do with the legal distinction between an experimental EUA product and an FDA-approved vaccine. Up until just weeks ago, this was the statement up on the CDC website via Pfizer:

“ Pfizer received FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals sixteen and older (COMIRNATY).   At that time, the FDA published a BLA package put that included the accepted new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs ( 0069-1000-03, 0069-1000-02 ) and images of labels with the new tradename.

At present, Pfizer does not plan to produce any kind of product with these new NDCs and labels over the following few months while EUA certified product is still available and being made available for Oughout. S. distribution .   As such, the CDC, AMA, and drug compendia might not publish these new requirements until Pfizer has motivated when the product will be created with the BLA labels. ”

Read more

Coronavirus Response Overblown And Eliminating The Economy

Leave a Reply

Your email address will not be published. Required fields are marked *